help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ko, L.
Right arrow Articles by Chin, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ko, L.
Right arrow Articles by Chin, W. W.
Molecular Endocrinology 16 (1): 128-140
Copyright © 2002 by The Endocrine Society

Ser-884 Adjacent to the LXXLL Motif of Coactivator TRBP Defines Selectivity for ERs and TRs

Lan Ko, Guemalli R. Cardona, Toshiharu Iwasaki, Kelli S. Bramlett, Thomas P. Burris and William W. Chin

Lilly Research Laboratories, Department of Gene Regulation, Bone and Inflammation Research, Eli Lilly & Co., Indianapolis, Indiana 46285

Address all correspondence and requests for reprints to: Dr. Lan Ko, Department of Gene Regulation, Bone & Inflammation Research, Lilly Corporate Center, Building 98/C, Drop Code 0434, Indianapolis, Indiana 46285. E-mail: kol{at}lilly.com

Ligand-dependent interaction of nuclear receptors and coactivators is a critical step in nuclear receptor-mediated transcriptional regulation. TR-binding protein (TRBP) interacts with nuclear receptors through a single LXXLL motif. Evidence suggested that the sequences flanking the LXXLL motif in a number of coactivators determine receptor selectivity. We performed mutagenesis studies at residues adjacent to the TRBP LXXLL motif and identified S884 of TRBP at the -3 position of the LXXLL motif as a key residue for receptor selectivity. Analysis of in vitro and in vivo receptor interactions with TRBP suggested that S884 allowed selective interactions for ERß, TR, and RXR vs. ER{alpha}. Transient transfection studies further confirmed that the LXXLL-binding affinity correlates with TRBP transcriptional activity. Consistent with the structural modeling, an E380G substitution within ER{alpha} altered the binding to TRBP mutants, demonstrating the direct contact between TRBP S884 and ER{alpha} E380, which is a residue that distinguishes receptor subclasses. Furthermore, S884 can be phosphorylated by MAPK in vitro, an event that significantly altered the binding of TRBP to ER and suggests a potential mechanism for regulatory interaction. As the differential recruitment of TRBP to ER{alpha} and ERß may rely on S884, our finding provides insight into estrogen signaling and may lead to the development of therapeutic receptor-selective peptide antagonists.




This article has been cited by other articles:


Home page
 Mol. Endocrinol.Home page
H. J. Dubbink, R. Hersmus, A. C. W. Pike, M. Molier, A. O. Brinkmann, G. Jenster, and J. Trapman
Androgen Receptor Ligand-Binding Domain Interaction and Nuclear Receptor Specificity of FXXLF and LXXLL Motifs as Determined by L/F Swapping
Mol. Endocrinol., August 1, 2006; 20(8): 1742 - 1755.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. A. Mahajan and H. H. Samuels
Nuclear Hormone Receptor Coregulator: Role in Hormone Action, Metabolism, Growth, and Development
Endocr. Rev., June 1, 2005; 26(4): 583 - 597.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Liu, B. O. Kim, C. Kao, C. Jung, J. T. Dalton, and J. J. He
Tip110, the Human Immunodeficiency Virus Type 1 (HIV-1) Tat-interacting Protein of 110 kDa as a Negative Regulator of Androgen Receptor (AR) Transcriptional Activation
J. Biol. Chem., May 21, 2004; 279(21): 21766 - 21773.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
C. L. Smith and B. W. O'Malley
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Endocr. Rev., February 1, 2004; 25(1): 45 - 71.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Takeuchi, H. H. Q. Heng, C. J. Ye, S.-B. Liang, J. Iwata, H. Sonobe, and Y. Ohtsuki
Down-Regulation of a Novel Actin-Binding Molecule, Skeletrophin, in Malignant Melanoma
Am. J. Pathol., October 1, 2003; 163(4): 1395 - 1404.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A.-M. Leduc, J. O. Trent, J. L. Wittliff, K. S. Bramlett, S. L. Briggs, N. Y. Chirgadze, Y. Wang, T. P. Burris, and A. F. Spatola
Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions
PNAS, September 30, 2003; 100(20): 11273 - 11278.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. H. Coulthard, S. Matsuda, and D. M. Heery
An Extended LXXLL Motif Sequence Determines the Nuclear Receptor Binding Specificity of TRAP220
J. Biol. Chem., March 21, 2003; 278(13): 10942 - 10951.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Ko and W. W. Chin
Nuclear Receptor Coactivator Thyroid Hormone Receptor-binding Protein (TRBP) Interacts with and Stimulates Its Associated DNA-dependent Protein Kinase
J. Biol. Chem., March 21, 2003; 278(13): 11471 - 11479.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
B. He and E. M. Wilson
Electrostatic Modulation in Steroid Receptor Recruitment of LXXLL and FXXLF Motifs
Mol. Cell. Biol., March 15, 2003; 23(6): 2135 - 2150.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Wu, W. W. Chin, Y. Wang, and T. P. Burris
Ligand and Coactivator Identity Determines the Requirement of the Charge Clamp for Coactivation of the Peroxisome Proliferator-activated Receptor gamma
J. Biol. Chem., February 28, 2003; 278(10): 8637 - 8644.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
Y.-H. Goo, Y. C. Sohn, D.-H. Kim, S.-W. Kim, M.-J. Kang, D.-J. Jung, E. Kwak, N. A. Barlev, S. L. Berger, V. T. Chow, et al.
Activating Signal Cointegrator 2 Belongs to a Novel Steady-State Complex That Contains a Subset of Trithorax Group Proteins
Mol. Cell. Biol., January 1, 2003; 23(1): 140 - 149.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
T. Suzuki, M. Kasahara, H. Yoshioka, K.-i. Morohashi, and K. Umesono
LXXLL-Related Motifs in Dax-1 Have Target Specificity for the Orphan Nuclear Receptors Ad4BP/SF-1 and LRH-1
Mol. Cell. Biol., January 1, 2003; 23(1): 238 - 249.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Schiff, S. Massarweh, J. Shou, and C. K. Osborne
Breast Cancer Endocrine Resistance: How Growth Factor Signaling and Estrogen Receptor Coregulators Modulate Response
Clin. Cancer Res., January 1, 2003; 9(1): 447s - 454s.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
P. J. Malloy, R. Xu, L. Peng, P. A. Clark, and D. Feldman
A Novel Mutation in Helix 12 of the Vitamin D Receptor Impairs Coactivator Interaction and Causes Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets without Alopecia
Mol. Endocrinol., November 1, 2002; 16(11): 2538 - 2546.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. J. McKenna and B. W. O'Malley
Minireview: Nuclear Receptor Coactivators--An Update
Endocrinology, July 1, 2002; 143(7): 2461 - 2465.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society